This patient-centered approach ensures safety and therapeutic success regardless of baseline BMI
Wilcox NS, Rui J, Hebrok M, Herold KC (2016) Life and death of cells in type 1 diabetes: a comprehensive review
doi: 10.1186/s10194-021-01271-1, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 204.Tamtaji OR, Milajerdi A, Reiner , Asemi Z, Dadgostar E, Heidari-Soureshjani R, et al
This session addresses the following ACGME Competencies: Medical Knowledge, Systems-based Practice This session addresses the following ICPE Competencies:Values and Ethics, Roles and Responsibilities Learning Objectives Upon completion, learners will be able to: describe the preclinical evidence in favor of repurposing GLP-1 receptor agonists as possible addiction pharmacotherapies recount the clinical trials studying the safety and efficacy of GLP-1 receptor agonists for addiction consider methods for providing fair and just access to new, expensive medications like GLP-1 receptor agonists to all segments of society Registration Rates *Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate
It's essential to understand that GLP-1 agonists are not new
